Health Indicator Report of Prostate Cancer Deaths
Prostate cancer is the second most commonly occurring form of cancer for men, and is the second leading cause of cancer death for men in both Utah and the U.S.
Prostate Cancer Deaths per 100,000 Men by Race, Utah, 2015-2019
NotesICD-10 codes used to define prostate cancer: C61. [[br]] Age-adjusted to U.S. 2000 standard population using 3 age groups, 0-44, 45-64, and 65+. [[br]] *Use caution in interpreting, the estimate has a relative standard error greater than 30% and does not meet UDOH standards for reliability. For more information, please go to [http://ibis.health.utah.gov/pdf/resource/DataSuppression.pdf].[[br]]
- Utah Death Certificate Database, Office of Vital Records and Statistics, Utah Department of Health
- Population Estimates by Age, Sex, Race, and Hispanic Origin for Counties in Utah, U.S. Bureau of the Census, IBIS Version 2019
DefinitionThe rate of death from cancer of the prostate (ICD-10: C61) per 100,000 men.
NumeratorThe number of deaths due to prostate cancer for a given year (ICD-10: C61).
DenominatorThe male population in Utah or the U.S. for a given year.
Healthy People Objective C-7:Reduce the prostate cancer death rate
U.S. Target: 21.8 deaths per 100,000 males
Other ObjectivesCSTE Chronic Disease Indicators
How Are We Doing?In 2019, the Utah age-adjusted prostate cancer mortality rate was 23.2 deaths per 100,000 males. Tooele County Local Health District had the highest prostate cancer mortality rate at 26.1 per 100,000 and Southwest Local Health District had the lowest at 15.7 (see additional data views for additional differences between Utah Small Areas) from 2015-2019. There was not a significant difference across ethnic groups from 2017-2019. From 2015-2019, men who racially identified as Asian had a significantly lower rate of prostate cancer mortality (3.5 deaths per 100,000 males) compared to other races, though caution should be used in interpreting these rates as these estimates have a high coefficient of variation.
How Do We Compare With the U.S.?The U.S. prostate cancer age-adjusted mortality rate has generally been decreasing over time, from 24.2 deaths per 100,000 males in 2007 to 18.9 deaths per 100,000 males in 2017. The Utah age-adjusted prostate cancer mortality rate trend has been more variable from year-to-year, though rates have generally been similar to the national rate. In 2017, the Utah age-adjusted prostate cancer mortality rate was 19.6 deaths per 100,000 males while the national rate was 18.9 deaths per 100,000 males.
What Is Being Done?The Utah Department of Health initiated the Utah Cancer Action Network (UCAN), a statewide partnership whose goal is to reduce the burden of cancer. The mission of the UCAN is to lower cancer incidence and mortality in Utah through collaborative efforts directed toward cancer prevention and control. As a result of this planning process, objectives and strategies have been developed by community partners regarding the early detection of cervical, breast, and colorectal cancers as well as the promotion of physical activity, healthy eating habits, melanoma cancer prevention, and cancer survivorship advocacy.
Evidence-based PracticesScreening recommendations have changed over time. Until recently, many doctors and professional organizations encouraged yearly PSA screening for men beginning at age 50. However, as more has been learned about both the benefits and harms of prostate cancer screening, a number of organizations have begun to caution against routine population screening. Although some organizations continue to recommend PSA screening, there is widespread agreement that any man who is considering getting tested should first be informed in detail about the potential harms and benefits. Since 2012 the U.S. Preventive Services Task Force (USPSTF) recommends against prostate-specific antigen (PSA)-based screening for prostate cancer. Healthy diet, exercise, and lifestyle play an important role in cancer prevention.
Available ServicesCurrently, Medicare provides coverage for an annual PSA test for all Medicare-eligible men age 50 and older. Many private insurers cover regular PSA screening tests as well. Check with your insurance provider and doctor's office to discuss when prostate cancer screening may be right for you.
Page Content Updated On 10/23/2020, Published on 01/05/2021